Mélanie Mercier

519 total citations
16 papers, 202 citations indexed

About

Mélanie Mercier is a scholar working on Pathology and Forensic Medicine, Epidemiology and Hematology. According to data from OpenAlex, Mélanie Mercier has authored 16 papers receiving a total of 202 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pathology and Forensic Medicine, 6 papers in Epidemiology and 6 papers in Hematology. Recurrent topics in Mélanie Mercier's work include Lymphoma Diagnosis and Treatment (6 papers), Hematopoietic Stem Cell Transplantation (4 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). Mélanie Mercier is often cited by papers focused on Lymphoma Diagnosis and Treatment (6 papers), Hematopoietic Stem Cell Transplantation (4 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). Mélanie Mercier collaborates with scholars based in France, Poland and Denmark. Mélanie Mercier's co-authors include Annabelle Servant‐Delmas, A Girault, Syria Laperche, Françoise Bouchardeau, Guillaume Cartron, David Ternant, Gilles Paintaud, Franck Morschhauser, Michel Meignan and T. Lamy and has published in prestigious journals such as Blood, Journal of Clinical Microbiology and Transplantation.

In The Last Decade

Mélanie Mercier

14 papers receiving 196 citations

Peers

Mélanie Mercier

PFM

GENET

HEMAT

EPIDE

RNMI

Vincenzo Cassibba Italy

Tuğrul Elverdi Türkiye

Aliki Xochelli Greece

M. Chartier France

Colin Phipps Diong Singapore

Eric Amante Australia

Krista Bean United States

Hira Shaikh United States

Man Fai Law China

CW McMillan United States

Vincenzo Cassibba Italy

Mélanie Mercier

42 ×0.6

PFM

36 ×0.6

GENET

77 ×1.4

HEMAT

43 ×0.8

EPIDE

8 ×0.2

RNMI

Citations per year, relative to Mélanie Mercier Mélanie Mercier (= 1×) peers Vincenzo Cassibba

Countries citing papers authored by Mélanie Mercier

Since Specialization

Citations

This map shows the geographic impact of Mélanie Mercier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mélanie Mercier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mélanie Mercier more than expected).

Fields of papers citing papers by Mélanie Mercier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mélanie Mercier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mélanie Mercier. The network helps show where Mélanie Mercier may publish in the future.

Co-authorship network of co-authors of Mélanie Mercier

This figure shows the co-authorship network connecting the top 25 collaborators of Mélanie Mercier. A scholar is included among the top collaborators of Mélanie Mercier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mélanie Mercier. Mélanie Mercier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Mercier, Mélanie, Corentin Orvain, Laurianne Drieu La Rochelle, et al.. (2021). Impact of High-Dose Methotrexate on the Outcome of Patients with Diffuse Large B-Cell Lymphoma and Skeletal Involvement. Cancers. 13(12). 2945–2945.

Lacout, Carole, Corentin Orvain, Valérie Seegers, et al.. (2020). R‐DHA‐oxaliplatin (R‐DHAOx) versus R‐DHA‐cisplatin (R‐DHAP) regimen in B‐cell lymphoma treatment: A eight‐year trajectory study. European Journal Of Haematology. 105(2). 223–230.

Cornillon, Jérôme, Élisabeth Daguenet, Jacques‐Olivier Bay, et al.. (2019). BAM conditioning before autologous transplantation for lymphoma: a study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC). Annals of Hematology. 98(8). 1973–1980. 1 indexed citations

Hayashi, Hiromi, Annalisa Ruggeri, Fernanda Volt, et al.. (2018). Chronic graft-versus-host disease features in double unit cord blood transplantation according to National Institutes of Health 2005 cGVHD Consensus criteria. Bone Marrow Transplantation. 53(4). 417–421. 1 indexed citations

Augeul-Meunier, Karine, Marie‐Lorraine Chrétien, Anne‐Marie Stoppa, et al.. (2018). Extending autologous transplantation as first line therapy in multiple myeloma patients with severe renal impairment: a retrospective study by the SFGM-TC. Bone Marrow Transplantation. 53(6). 749–755. 14 indexed citations

Orvain, Corentin, François Beloncle, Jean‐François Hamel, et al.. (2018). Allogeneic stem cell transplantation recipients requiring intensive care: time is of the essence. Annals of Hematology. 97(9). 1601–1609. 8 indexed citations

Farhi, Jonathan, Kamel Laribi, Corentin Orvain, et al.. (2018). Impact of front line relative dose intensity for methotrexate and comorbidities in immunocompetent elderly patients with primary central nervous system lymphoma. Annals of Hematology. 97(12). 2391–2401. 14 indexed citations

Gorin, Norbert Claude, Myriam Labopin, Thomas Pabst, et al.. (2017). Unrelated matched versus autologous transplantation in adult patients with good and intermediate risk acute myelogenous leukemia in first molecular remission. American Journal of Hematology. 92(12). 1318–1323. 18 indexed citations

Casasnovas, Olivier, Michel Meignan, T. Lamy, et al.. (2017). Rituximab exposure is influenced by baseline metabolic tumor volume and predicts outcome of DLBCL patients: a Lymphoma Study Association report. Blood. 129(19). 2616–2623. 64 indexed citations

10.

Orvain, Corentin, François Beloncle, Jean‐François Hamel, et al.. (2016). Different Impact of the Number of Organ Failures and Graft-Versus-Host Disease on the Outcome of Allogeneic Stem Cell Transplantation Recipients Requiring Intensive Care. Transplantation. 101(2). 437–444. 9 indexed citations

11.

Gagez, Anne-Laure, Stéphane Leprêtre, Valérie Gouilleux‐Gruart, et al.. (2016). Influence of FCGR3A-158V/F Genotype and Baseline CD20 Antigen Count on Target-Mediated Elimination of Rituximab in Patients with Chronic Lymphocytic Leukemia: A Study of FILO Group. Clinical Pharmacokinetics. 56(6). 635–647. 22 indexed citations

12.

Augeul-Meunier, Karine, Denis Caillot, Anne‐Marie Stoppa, et al.. (2016). Extending Autologous Hematopoietic Stem Cell Transplantation As First Line Treatment in Multiple Myeloma Patients with Severe Renal Impairment: A Retrospective Study of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC). Blood. 128(22). 4637–4637. 1 indexed citations

13.

Lacout, Carole, Aline Clavert, Jonathan Farhi, et al.. (2015). R-DHA-Oxaliplatin Versus R-DHA-Cisplatin Regimen in B-Cell Nhl's Treatment: A Eight Years Retrospective Study. Blood. 126(23). 3959–3959. 1 indexed citations

14.

Servant‐Delmas, Annabelle, Mélanie Mercier, A Girault, et al.. (2010). National survey of hepatitis B virus (HBV) polymorphism in asymptomatic HBV blood donors from 1999 to 2007 in France. Transfusion. 50(12). 2607–2618. 29 indexed citations

15.

Mercier, Mélanie, Syria Laperche, A Girault, Camille Sureau, & Annabelle Servant‐Delmas. (2010). Overestimation of Incidence of Hepatitis B Virus Mixed-Genotype Infections by Use of the New Line Probe INNO-LiPA Genotyping Assay. Journal of Clinical Microbiology. 49(3). 1154–1156. 7 indexed citations

16.

Bouchardeau, Françoise, et al.. (2006). Sensitivity of hepatitis B virus DNA transcription‐mediated amplification testing in hepatitis B surface antigen–positive blood donations. Transfusion. 46(12). 2047–2052. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact